Worth Venture Partners, LLC - ARCTURUS THERAPEUTICS LTD ownership

ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105. A total of 23 filers reported holding ARCTURUS THERAPEUTICS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of ARCTURUS THERAPEUTICS LTD
ValueSharesWeighting
Q3 2018$290,000
+58.5%
32,848
-1.0%
0.22%
+37.1%
Q1 2018$183,000
-40.8%
33,184
-14.6%
0.16%
-53.5%
Q4 2017$309,00038,8540.34%
Other shareholders
ARCTURUS THERAPEUTICS LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 32,848$290,0000.22%
ARK Investment Management 773,772$6,840,0000.21%
ROYCE & ASSOCIATES LP 106,436$941,0000.01%
Independence Bank of Kentucky 607$5,0000.00%
OXFORD ASSET MANAGEMENT LLP 18,700$164,0000.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 27,300$241,0000.00%
GROUP ONE TRADING, L.P. 4,086$36,0000.00%
1832 Asset Management L.P. 560$5,0000.00%
CITIGROUP INC 171$2,0000.00%
MORGAN STANLEY 47,965$424,0000.00%
View complete list of ARCTURUS THERAPEUTICS LTD shareholders